In order to further explore the effect of METTL3 on endostar combined with cisplatin in the treatment of NSCLC mice, we constructed METTL3 overexpression and knockdown cell lines to construct a mouse tumor-bearing model. Here, METTL3 is linked to non-small cell lung carcinoma.